Prevention and therapy of fungal infection in severe acute pancreatitis: A prospective clinical study

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 9, Issue 11

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

279

HTML

2166

Tables (1-3)

160

Sum=2605

Nov 15, 2003 (publication date) through Jul 29, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Reports

World J Gastroenterol. Nov 15, 2003; 9(11): 2619-2621
Published online Nov 15, 2003. doi: 10.3748/wjg.v9.i11.2619

Table 2 Incidence rate of fungal infection in 3 groups

Group	Cases	Rate of fungal infection	Times of fungal infection after SAP (d)
Garlicin	25	4 (16%)^a	39-57
Fluconazole	22	2 (9%)^b	35-62
Control	23	7 (30%)	24-183

^aP < 0.05,

^bP < 0.01 vs control.

Citation: He YM, Lv XS, Ai ZL, Liu ZS, Qian Q, Sun Q, Chen JW, Lei DX, Jiang CQ, Yuan YF. Prevention and therapy of fungal infection in severe acute pancreatitis: A prospective clinical study. World J Gastroenterol 2003; 9(11): 2619-2621
URL: https://www.wjgnet.com/1007-9327/full/v9/i11/2619.htm
DOI: https://dx.doi.org/10.3748/wjg.v9.i11.2619